Proteomics comparison of the sera from multiple sclerosis patients and neuromyelitis optica patients

Genetics and Molecular Research

Volumn 13, Issue 4, 2014, Pages 9292-9299

  Jiang, S F ^a   Lu, Q Y ^b   Hu, S ^b   Chen, Y ^a   Liu, X L ^c   Yang, Y ^a   Ding, M P ^a  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Hangzhou Air Force Aeromedicine Assessment and Training Centre   (China)

^c ZHEJIANG HOSPITAL   (China)

Author keywords

Multiple sclerosis; Neuromyelitis optica; Proteomics

Indexed keywords

HAPTOGLOBIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G LAMBDA; KERATIN; KERATIN 83; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; ENZYME ACTIVITY; ENZYME METABOLISM; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEOMICS; SILVER STAINING; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; YOUNG ADULT; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY;

ADULT; CASE-CONTROL STUDIES; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; PROTEOMICS; YOUNG ADULT;

EID: 84909942507     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2014.February.14.3     Document Type: Article

References (20)

1. Argyriou AA and Makris N (2008). Neuromyelitis optica: a distinct demyelinating disease of the central nervous system. Acta Neurol. Scand. 118: 209-217.
2. Bergamaschi R, Tonietti S, Franciotta D, Candeloro E, et al. (2004). Oligoclonal bands in Devic’s neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations. Mult. Scler. 10: 2-4.
3. Butler JE, Zhao Y, Sinkora M, Wertz N, et al. (2009). Immunoglobulins, antibody repertoire and B cell development. Dev. Comp. Immunol. 33: 321-333.
4. Davidsson P, Sjogren M, Andreasen N, Lindbjer M, et al. (2002). Studies of the pathophysiological mechanisms in frontotemporal dementia by proteome analysis of CSF proteins. Brain Res. Mol. Brain Res. 109: 128-133.
5. Genain CP, Cannella B, Hauser SL and Raine CS (1999). Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med. 5: 170-175.
6. Hansson SF, Puchades M, Blennow K, Sjogren M, et al. (2004). Validation of a prefractionation method followed by two-dimensional electrophoresis - Applied to cerebrospinal fluid proteins from frontotemporal dementia patients. Proteome Sci. 2: 7.
7. Hauser SL, Waubant E, Arnold DL, Vollmer T, et al. (2008). B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 358: 676-688.
8. Lana-Peixoto MA (2008). Devic’s neuromyelitis optica: a critical review. Arq. Neuropsiquiatr. 66: 120-138.
9. Langlois MR and Delanghe JR (1996). Biological and clinical significance of haptoglobin polymorphism in humans. Clin. Chem. 42: 1589-1600.
10. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, et al. (2004). A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364: 2106-2112.
11. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, et al. (2005). IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J. Exp. Med. 202: 473-477.
12. Lucchinetti C (2008). Pathological heterogeneity of idiopathic central nervous system inflammatory demyelinating disorders. Curr. Top. Microbiol. Immunol. 318: 19-43.
13. Matiello M, Jacob A, Wingerchuk DM and Weinshenker BG (2007). Neuromyelitis optica. Curr. Opin. Neurol. 20: 255-260.
14. Noseworthy JH (1999). Progress in determining the causes and treatment of multiple sclerosis. Nature 399: A40-A47.
15. O’Bryan MK, Grima J, Mruk D and Cheng CY (1997). Haptoglobin is a Sertoli cell product in the rat seminiferous epithelium: its purification and regulation. J. Androl. 18: 637-645.
16. Papeix C, Vidal JS, de Seze J, Pierrot-Deseilligny C, et al. (2007). Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult. Scler. 13: 256-259.
17. Rithidech KN, Honikel L, Milazzo M, Madigan D, et al. (2009). Protein expression profiles in pediatric multiple sclerosis: potential biomarkers. Mult. Scler. 15: 455-464.
18. Saiz A, Zuliani L, Blanco Y, Tavolato B, et al. (2007). Revised diagnostic criteria for neuromyelitis optica (NMO). Application in a series of suspected patients. J. Neurol. 254: 1233-1237.
19. Sawai S, Umemura H, Mori M, Satoh M, et al. (2010). Serum levels of complement C4 fragments correlate with disease activity in multiple sclerosis: proteomic analysis. J. Neuroimmunol. 218: 112-115.
20. Wagner L, Gessl A, Parzer SB, Base W, et al. (1996). Haptoglobin phenotyping by newly developed monoclonal antibodies. Demonstration of haptoglobin uptake into peripheral blood neutrophils and monocytes. J. Immunol. 156: 1989-1996.